Table 1. Patient characteristics (n=77).
| Characteristic | Number (%) |
|---|---|
| Age, years | |
| Median, range | 70 (36, 92) |
| Sex, male | 46 (60) |
| Performance status | |
| 0 | 22 (29) |
| 1 | 44 (57) |
| 2 | 11 (14) |
| Lymphoma stage at study entry | |
| 1, 2 | 10 (13) |
| 3, 4 | 67 (87) |
| Disease type | |
| DLBCL | 47 (61) |
| MCL | 19 (25) |
| FL-III | 8 (10) |
| TL | 1 (1) |
| Precursor T-lymphoblastic leukemia/lymphoma | 1 (1) |
| Unspecified high-grade B-cell lymphoma | 1 (1) |
| Previous stem cell transplant | 25 (32) |
| Presence of B symptoms | 7 (9) |
| Number of previous therapy treatments | |
| Median, range | 3 (1, 15) |
| Type of previous therapy | |
| Rituximab | 74 (96) |
| Anthracycline | 70 (91) |
Abbreviations: DLBCL, diffuse large B-cell lymphoma; FL-III, follicular lymphoma grade III; MCL, mantle cell lymphoma; TL, transformed lymphoma.